Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Aeglea BioTherapeutics Inc.
DescriptionEngineered enzyme that degrades methionine
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today